{"PubmedArticle": [{"MedlineCitation": {"SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "OtherAbstract": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "PMID": "17284681", "DateCompleted": {"Year": "2007", "Month": "11", "Day": "09"}, "DateRevised": {"Year": "2022", "Month": "03", "Day": "10"}, "Article": {"ArticleDate": [{"Year": "2007", "Month": "02", "Day": "06"}], "Language": ["eng"], "ELocationID": [], "Journal": {"ISSN": "0741-5400", "JournalIssue": {"Volume": "81", "Issue": "5", "PubDate": {"Year": "2007", "Month": "May"}}, "Title": "Journal of leukocyte biology", "ISOAbbreviation": "J Leukoc Biol"}, "ArticleTitle": "(S)-armepavine inhibits human peripheral blood mononuclear cell activation by regulating Itk and PLCgamma activation in a PI-3K-dependent manner.", "Pagination": {"StartPage": "1276", "EndPage": "1286", "MedlinePgn": "1276-86"}, "Abstract": {"AbstractText": ["Chinese herbs are useful edible and medicinal plants for their immune modulatory functions. We have proven that (S)-armepavine (C19H23O3N; MW313) from Nelumbo nucifera inhibits the proliferation of human PBMCs activated with PHA and improves autoimmune diseases in MRL/MpJ-lpr/lpr mice. In the present study, the pharmacological activities of (S)-armepavine were evaluated in PHA-activated PBMCs. The results showed that (S)-armepavine suppressed PHA-induced PBMC proliferation and genes expression of IL-2 and IFN-gamma without direct cytotoxicity. Inhibition of NF-AT and NF-kappaB activation suggested phospholipase Cgamma (PLCgamma)-mediated Ca2+ mobilization and protein kinase C activation were blocked by (S)-armepavine. Phosphorylation of PLCgamma is regulated by lymphocyte-specific kinase (Lck), ZAP-70, and IL-2-inducible T cell kinase (Itk). We found (S)-armepavine inhibited PHA-induced phosphorylation of Itk and PLCgamma efficiently but did not influence Lck or ZAP-70 phosphorylation. In addition, ZAP-70-mediated pathways, such as the association of linker for activation of T cells with PLCgamma and activation of ERK, were also intact in the presence of (S)-armepavine. Finally, reduction of phosphoinositide 3,4,5-trisphosphate formation and Akt phosphorylation suggested that (S)-armepavine inhibited Itk, and PLCgamma phosphorylation might be a result of the influence of PI-3K activation. Addition of exogenous IL-2 or PMA/A23187 rescued PBMC proliferation in the presence of (S)-armepavine. Therefore, we concluded that (S)-armepavine inhibited PHA-induced cell proliferation and cytokine production in a major way by blocking membrane-proximal effectors such as Itk and PLCgamma in a PI-3K-dependent manner."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Pharmacology, National Yang-Ming University, Laboratory of Biochemistry, National Research Institute of Chinese Medicine, No. 155-1, Sec. 2, Li-Nung St., Shih-Pai, 112, Taipei, Taiwan, ROC."}], "Identifier": [], "LastName": "Liu", "ForeName": "Chih-Peng", "Initials": "CP"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Kuo", "ForeName": "Yuh-Chi", "Initials": "YC"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Shen", "ForeName": "Chien-Chang", "Initials": "CC"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Wu", "ForeName": "Ming-Hsi", "Initials": "MH"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Liao", "ForeName": "Jyh-Fei", "Initials": "JF"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Lin", "ForeName": "Yun-Lian", "Initials": "YL"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Chen", "ForeName": "Chieh-Fu", "Initials": "CF"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Tsai", "ForeName": "Wei-Jern", "Initials": "WJ"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "J Leukoc Biol", "NlmUniqueID": "8405628", "ISSNLinking": "0741-5400"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Alkaloids"}, {"RegistryNumber": "0", "NameOfSubstance": "Benzylisoquinolines"}, {"RegistryNumber": "0", "NameOfSubstance": "Interleukin-2"}, {"RegistryNumber": "0", "NameOfSubstance": "NF-kappa B"}, {"RegistryNumber": "0", "NameOfSubstance": "NFATC Transcription Factors"}, {"RegistryNumber": "0", "NameOfSubstance": "Phosphoinositide-3 Kinase Inhibitors"}, {"RegistryNumber": "0", "NameOfSubstance": "RNA, Messenger"}, {"RegistryNumber": "37H9VM9WZL", "NameOfSubstance": "Calcimycin"}, {"RegistryNumber": "82115-62-6", "NameOfSubstance": "Interferon-gamma"}, {"RegistryNumber": "EC 2.7.10.1", "NameOfSubstance": "Protein-Tyrosine Kinases"}, {"RegistryNumber": "EC 2.7.10.2", "NameOfSubstance": "emt protein-tyrosine kinase"}, {"RegistryNumber": "EC 2.7.11.13", "NameOfSubstance": "Protein Kinase C"}, {"RegistryNumber": "EC 3.1.4.3", "NameOfSubstance": "Phospholipase C gamma"}, {"RegistryNumber": "NI40JAQ945", "NameOfSubstance": "Tetradecanoylphorbol Acetate"}, {"RegistryNumber": "RE6Z59021R", "NameOfSubstance": "armepavine"}, {"RegistryNumber": "SY7Q814VUP", "NameOfSubstance": "Calcium"}], "MeshHeadingList": [{"QualifierName": ["chemistry", "isolation & purification", "pharmacology"], "DescriptorName": "Alkaloids"}, {"QualifierName": ["chemistry", "isolation & purification", "pharmacology"], "DescriptorName": "Benzylisoquinolines"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Calcimycin"}, {"QualifierName": ["antagonists & inhibitors", "metabolism"], "DescriptorName": "Calcium"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Proliferation"}, {"QualifierName": [], "DescriptorName": "Dose-Response Relationship, Drug"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["antagonists & inhibitors", "biosynthesis"], "DescriptorName": "Interferon-gamma"}, {"QualifierName": ["antagonists & inhibitors", "biosynthesis"], "DescriptorName": "Interleukin-2"}, {"QualifierName": ["drug effects", "immunology"], "DescriptorName": "Leukocytes, Mononuclear"}, {"QualifierName": [], "DescriptorName": "Molecular Conformation"}, {"QualifierName": [], "DescriptorName": "Molecular Weight"}, {"QualifierName": ["antagonists & inhibitors", "metabolism"], "DescriptorName": "NF-kappa B"}, {"QualifierName": ["antagonists & inhibitors", "metabolism"], "DescriptorName": "NFATC Transcription Factors"}, {"QualifierName": ["chemistry"], "DescriptorName": "Nelumbo"}, {"QualifierName": ["biosynthesis", "metabolism"], "DescriptorName": "Phosphatidylinositol 3-Kinases"}, {"QualifierName": [], "DescriptorName": "Phosphoinositide-3 Kinase Inhibitors"}, {"QualifierName": ["drug effects", "metabolism"], "DescriptorName": "Phospholipase C gamma"}, {"QualifierName": [], "DescriptorName": "Phosphorylation"}, {"QualifierName": ["antagonists & inhibitors", "metabolism"], "DescriptorName": "Protein Kinase C"}, {"QualifierName": ["drug effects", "metabolism"], "DescriptorName": "Protein-Tyrosine Kinases"}, {"QualifierName": ["antagonists & inhibitors", "biosynthesis"], "DescriptorName": "RNA, Messenger"}, {"QualifierName": ["chemistry"], "DescriptorName": "Seeds"}, {"QualifierName": [], "DescriptorName": "Structure-Activity Relationship"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Tetradecanoylphorbol Acetate"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2007", "Month": "2", "Day": "8", "Hour": "9", "Minute": "0"}, {"Year": "2007", "Month": "11", "Day": "10", "Hour": "9", "Minute": "0"}, {"Year": "2007", "Month": "2", "Day": "8", "Hour": "9", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["17284681", "10.1189/jlb.0106056", "jlb.0106056"]}}], "PubmedBookArticle": []}